Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles

George Richard Thompson; Derek Bays; Stuart H Cohen; Demosthenes Pappagianis

doi:10.1128/AAC.05275-11

Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles

George Richard Thompson, Derek Bays, Stuart H Cohen, Demosthenes Pappagianis

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.

Original language	English (US)
Pages (from-to)	563-564
Number of pages	2
Journal	Antimicrobial Agents and Chemotherapy
Volume	56
Issue number	1
DOIs	https://doi.org/10.1128/AAC.05275-11
State	Published - Jan 2012

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology
Infectious Diseases

Access to Document

10.1128/AAC.05275-11

Fingerprint Dive into the research topics of 'Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles'. Together they form a unique fingerprint.

Cite this

@article{65dd962ee6c543e5b9309a25b2839e83,

title = "Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: An assessment of currently available triazoles",

abstract = "The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.",

author = "Thompson, {George Richard} and Derek Bays and Cohen, {Stuart H} and Demosthenes Pappagianis",

year = "2012",

month = jan,

doi = "10.1128/AAC.05275-11",

language = "English (US)",

volume = "56",

pages = "563--564",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "1",

}

TY - JOUR

T1 - Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy

T2 - An assessment of currently available triazoles

AU - Thompson, George Richard

AU - Bays, Derek

AU - Cohen, Stuart H

AU - Pappagianis, Demosthenes

PY - 2012/1

Y1 - 2012/1

N2 - The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.

AB - The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.

UR - http://www.scopus.com/inward/record.url?scp=84455192484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84455192484&partnerID=8YFLogxK

U2 - 10.1128/AAC.05275-11

DO - 10.1128/AAC.05275-11

M3 - Article

C2 - 22005993

AN - SCOPUS:84455192484

VL - 56

SP - 563

EP - 564

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -